These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3987592)

  • 1. The derivation of nitrosamines from some therapeutic amines in the human environment.
    Akintonwa DA
    Ecotoxicol Environ Saf; 1985 Feb; 9(1):64-70. PubMed ID: 3987592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ester-mediated nitrosamine formation from nitrite and secondary or tertiary amines.
    Loeppky RN; Tomasik W; Millard TG
    IARC Sci Publ; 1984; (57):353-63. PubMed ID: 6533026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of drugs with nitrous acid as a source of carcinogenic nitrosamines.
    Lijinsky W
    Cancer Res; 1974 Jan; 34(1):255-8. PubMed ID: 4148978
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitrosamine formation via non-prescription drugs?
    Nielsen JB; Lings S
    Med Hypotheses; 1994 Apr; 42(4):265-8. PubMed ID: 7915398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deuterium isotope effect in the microsomal metabolism of dimethylnitrosamine.
    Dagani D; Archer MC
    J Natl Cancer Inst; 1976 Oct; 57(4):955-7. PubMed ID: 1003536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further investigation about the endogenous formation of cancerogenic N-nitroso-derivatives. 2. (author's transl)].
    Bicker U; Osske G
    Arch Geschwulstforsch; 1974; 43(3):244-9. PubMed ID: 4848812
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic activation of aromatic amines and dialkylnitrosamines.
    Lotlikar PD
    J Cancer Res Clin Oncol; 1981; 99(1-2):125-36. PubMed ID: 7251630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for Assessing Acceptable Intakes for Novel
    Ponting DJ; Dobo KL; Kenyon MO; Kalgutkar AS
    J Med Chem; 2022 Dec; 65(23):15584-15607. PubMed ID: 36441966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of volatile nitrosamines by drug-nitrite interactions under physiological conditions.
    Sakai A; Inoue T; Tanimura A
    Gan; 1984 Mar; 75(3):245-52. PubMed ID: 6724228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical carcinogenesis.
    Heidelberger C
    Annu Rev Biochem; 1975; 44():79-121. PubMed ID: 1094923
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the binding of chlorpromazine and chloroquine to melanin in vivo.
    Tjälve H; Nilsson M; Larsson B
    Biochem Pharmacol; 1981 Jul; 30(13):1845-7. PubMed ID: 7271873
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of carcinogenic amino derivatives in various species and DNA alkylation by their metabolites.
    Schut HA; Castonguay A
    Drug Metab Rev; 1984; 15(4):753-839. PubMed ID: 6437779
    [No Abstract]   [Full Text] [Related]  

  • 14. Formation of N-nitrosamines from sodium nitroprusside and secondary amines.
    Park JW; Means GE
    N Engl J Med; 1985 Dec; 313(24):1547-8. PubMed ID: 4069167
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid formation of N-nitrosamines from nitrogen oxides under neutral and alkaline conditions.
    Challis BC; Edwards A; Hunma RR; Kyrtopoulos SA; Outram JR
    IARC Sci Publ (1971); 1978; (19):127-42. PubMed ID: 28274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.
    Back DJ; Purba HS; Staiger C; Orme ML; Breckenridge AM
    Biochem Pharmacol; 1983 Jan; 32(2):257-63. PubMed ID: 6870955
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug interactions. II. Formation of nitrosamines from therapeutic drugs. Properties and kinetics of the formation of N-nitrosopropranolol from nitrite and the secondary amine propranolol hydrochloride.
    Chen J; Raisfeld-Danse IH
    J Pharmacol Exp Ther; 1983 Jun; 225(3):705-12. PubMed ID: 6864529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrocellulose blister material as a source of N-nitrosamine contamination of pharmaceutical drug products.
    Golob N; Grahek R; Ross M; Roškar R
    Int J Pharm; 2022 Apr; 618():121687. PubMed ID: 35314277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of nitrosamines and precursor secondary amines under methanogenic conditions.
    Tezel U; Padhye LP; Huang CH; Pavlostathis SG
    Environ Sci Technol; 2011 Oct; 45(19):8290-7. PubMed ID: 21863807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of nitrosamine and nitramine formation from NOx reactions with amines during amine-based carbon dioxide capture for postcombustion carbon sequestration.
    Dai N; Shah AD; Hu L; Plewa MJ; McKague B; Mitch WA
    Environ Sci Technol; 2012 Sep; 46(17):9793-801. PubMed ID: 22831707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.